ÂÜÀòÂÒÂ×

Geoff Oxnard serves as the Chief Medical Officer at BlossomHill Therapeutics, Inc. since January 2025 and is also a Thoracic Oncologist at Boston Medical Center since April 2021. Prior to these roles, Geoff held significant positions at Loxo@Lilly as Vice President of Clinical Development, and at Foundation Medicine, where Geoff was the Senior Vice President and Head of Clinical Development. Geoff's career includes leadership roles in clinical development at Dana-Farber Cancer Institute and academic positions at Harvard Medical School. Geoff began medical training as a Medical Oncology Fellow at Memorial Sloan-Kettering Cancer Center following education at The University of Chicago Pritzker School of Medicine and Harvard University.